7-HYDROXYWARFARIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
TERFENADINE ALCOHOL METABOLITE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
GLUTATHIONE REDUCTASE
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY
UDP-GLUCURONOSYLTRANSFERASE SF9WT
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY
CARBOXYTOLBUTAMIDE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MXR-MEMBRANE PREPARATION, HUMAN
MXR human, membrane preparation, wild type variant, for Vesicular Transport
DL-BUTHIONINE-(S,R)-SULFOXIMINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
CYTOCHROME P450 CYP1A1 ISOZYME*MICROSOMES, HUMAN
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, OXIDATIVE PATHWAY
MORPHINE-3,6-DIGLUCURONIDE TETRAHYDRATE, DEA SCHEDULE II
Morphine-3,6-diglucuronide tetrahydrate, To be determined
MIDAZOLAM-(METHYL,1,3A,4-13C4-5-15N) MALEATE SALT, DEA SCHEDULE III
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES